Enhancer ID: | E_02_0344 |
Species: | human |
Position : | chr8:127732819-127734819 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Prostate cancer |
Pubmed ID: | 32617979 |
Enhancer experiment: | RNA seq,ChIP assay,Immunohistochemistry, |
Enhancer experiment description: | Overexpression of KDM4B promoted recruitment of AR to the c-Myc (MYC) gene enhancer and induced H3K10 demethylation, increasing AR-dependent transcription of c-Myc mRNA, which regulates the sensitivity to next generation AR-targeted therapy. |
Target gene : | MYC(MRTLC,bHLHe39,c-Myc) |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | Overexpression of KDM4B promoted recruitment of AR to the c-Myc (MYC) gene enhancer and induced H3K10 demethylation, increasing AR-dependent transcription of c-Myc mRNA, which regulates the sensitivity to next generation AR-targeted therapy. |
TF name : | -- |
TF experiment: | RNA seq,ChIP assay,Immunohistochemistry, |
TF experiment description: | Overexpression of KDM4B promoted recruitment of AR to the c-Myc (MYC) gene enhancer and induced H3K10 demethylation, increasing AR-dependent transcription of c-Myc mRNA, which regulates the sensitivity to next generation AR-targeted therapy. |
Enhancer function : | Overexpression of KDM4B promoted recruitment of AR to the c-Myc (MYC) gene enhancer and induced H3K10 demethylation, increasing AR-dependent transcription of c-Myc mRNA, which regulates the sensitivity to next generation AR-targeted therapy. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
Overexpression of KDM4B promoted recruitment of AR to the c-Myc (MYC) gene enhancer and induced H3K10 demethylation, increasing AR-dependent transcription of c-Myc mRNA, which regulates the sensitivity to next generation AR-targeted therapy. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|